Vitamin K Supplementation for the Prevention of Cardiovascular Disease: Where Is the Evidence? A Systematic Review of Controlled Trials
Matrix gla protein (MGP) is an important vitamin K-dependent inhibitor of vascular calcification. High levels of uncarboxylated, dephosphorylated MGP have been associated with vascular calcification and are responsive to vitamin K treatment. In this systematic review, we summarize the available evid...
Main Authors: | Caitlyn Vlasschaert, Chloe J. Goss, Nathan G. Pilkey, Sandra McKeown, Rachel M. Holden |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/12/10/2909 |
Similar Items
-
Effect of vitamin K1 supplementation on matrix Gla protein level and vascular calcification in hemodialysis patients
by: Ahmed Alla Eldin Ahmed Saad, et al.
Published: (2017-01-01) -
Vitamin K and vascular calcification in chronic kidney disease: An update of current evidence
by: Yu-Li Lin, et al.
Published: (2023-01-01) -
Extrahepatic Vitamin K-Dependent Gla-Proteins–Potential Cardiometabolic Biomarkers
by: Bistra Galunska, et al.
Published: (2024-03-01) -
Vitamin K and Calcium Chelation in Vascular Health
by: Jan O. Aaseth, et al.
Published: (2023-11-01) -
Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases?
by: Ianthe Piscaer, et al.
Published: (2017-11-01)